|
Betulinic
Acid
Betulinic acid, a pentacyclic triterpene, is a component of
the bark of the white birch tree, Betula alba. The
tree is fast growing and abundant in North America and Europe.
The raw material is readily available in large quantities
since birch bark is considered a waste product in the pulp
and paper, and furniture manufacturing industries.
Betulinic
acid is a pentacyclic triterpene that has demonstrated cytotoxic
activity specific for melanoma cells both in vitro
and in vivo. In vitro, this melanoma-specific
cytotoxicity occurs through apoptosis; however, this mechanism
is not well understood. When administered intraperitoneally
to athymic mice bearing human melanoma xenografts, betulinic
acid is concentrated in the tumors, resulting in rapid tumor
regression with no observable toxicity to the animal even
at high doses (e.g., 500 mg/Kg body weight, i.p.). Direct
injection of betulinic acid into the tumor of xenografts induced
apoptosis within the tumors (Pezzuto et al., 1999).
Betulinic
acid is relatively nontoxic, and found in the bark of white
birch at concentrations of up to 1 to 2% by weight. Betulin,
its non-bioactive precursor, is also found in the bark of
white birch at concentrations of up to 25% by weight. Betulinic
acid, the bioactive target, can be manufactured from betulin
in a 2-step semi-synthetic process (Jones oxidation [CrO3/H2SO4/acetone/0°C],
NaBH4 reduction and re-crystallization
in methanol) with an overall yield of approximately 71% (Kim
et al., 1997). This process may, however, be difficult to
scale because of the solvents utilized and their expense.
Aphios
Corporation has developed an improved process for manufacturing
betulin and betulinic acid from birch bark. The process utilizes
Aphios' SuperFluids™ CXP manufacturing technology and
proprietary downstream purification processes. Research leading
to these developments was made under Phase I&II Fast Track
Small Business Innovative Research (SBIR) contracts from the
National Cancer Institute (NCI), United States National Institutes
of Health (NIH).
Home
l Company | Infectious
Diseases | Oncology | Nutraceuticals
| Product Pipeline | Purchase
Products | Technology Platforms
| Equipment |Patents
| Press
Releases | Contact Aphios
©1999-
2007 Aphios® Corporation
All rights reserved
|